A real-world study of antifibrotic drugs-related adverse events based on the United States food and drug administration adverse event reporting system and VigiAccess databases

• Ngā kaituhi matua: Menglin He (Author), Taoran Yang (Author), Jian Zhou (Author), Rurong Wang (Author), Xuehan Li (Author)
• Hōputu: Pukapuka
• I whakaputaina: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• Ngā marau: article
• Urunga tuihono: Connect to this object online.

Objectives: This study aims to investigate adverse events (AEs) and adverse drug reactions (ADRs) associated with pirfenidone and nintedanib, two antifibrotic drugs used to treat idiopathic pulmonary fibrosis (IPF).Methods: Reporting odds ratio (ROR) and proportional reporting ratio (PRR) analyses w...